Latvia vs United States of America: Proportion of the target population who received the final dose of
Latvia
51.0%
in 2024
United States of America
52.0%
in 2024
Latvia rank
73rd
United States of America rank
71st
Proportion of the target population who received the final dose of over time
- Latvia
- United States of America
How they compare
United States of America currently reports 52.0% against 51.0% in Latvia, a difference of 1.0%.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Latvia ahead.
Latvia ranks 73rd and United States of America ranks 71st of 107 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Latvia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.1% | 32.6% | 9.6% | Latvia |
| 2020s | 43.6% | 50.8% | 7.2% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latvia or United States of America?
- United States of America, at 52.0% against 51.0% in Latvia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latvia and United States of America?
- 1.0%, with United States of America ahead.
- How many years of comparable data are there for Latvia and United States of America?
- 14 years are reported by both, from 2011 to 2024.
- How do Latvia and United States of America rank globally for proportion of the target population who received the final dose of?
- Latvia ranks 73rd and United States of America ranks 71st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.